Rules Navigator

Register

DEA, HHS extend telemedicine waivers for prescribing controlled medications

Male doctor engaging with male patient over computer (telemedicine).
Photo: Brooks Kraft LLC/Corbis via Getty Images

Kevin Kinsella

 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Under the temporary rule, patients who rely on telemedicine can continue accessing care without fear of falling off the so-called “telemedicine cliff.”

The US Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) issued a notice of proposed rulemaking (NPRM) for the fourth extension of a waiver for prescribing controlled substances via telemedicine for patients without a prior in-person visit.

The temporary rule ensures that people who rely

Register for free to keep reading

To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.

  • Unlimited access to industry insights
  • Stay on top of key rules and regulatory changes with our Rules Navigator
  • Ad-free experience with no distractions
  • Regular podcasts from trusted external experts
  • Fresh compliance and regulatory content every day
Register for free
Sign in
, , , , , ,